Lumasiran drug achieves primary and secondary endpoints in Phase III study
Lumasiran, an investigational drug to treat primary hyperoxaluria type 1,…
Lumasiran, an investigational drug to treat primary hyperoxaluria type 1, has met its endpoints in clinical trials.